Michael Egholm - 04 Apr 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Reporting owner
Signature
/s/ Michael Egholm by Hanjoon Alex Kim, Attorney-in-Fact
Issuer context
Transaction snapshot
SEC evidence
Form type
4
Filing time
08 Apr 2025, 16:04:11 UTC
Previous filing
24 Mar 2025
Next filing
22 May 2025
SEC filing
View on sec.gov

Key filing fact

Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 08 Apr 2025.

Key facts

  • This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
  • 3 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 08 Apr 2025, 16:04.

Change

  • Previous filing in this sequence was filed on 24 Mar 2025.
  • Current net transaction value: -$61,713.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

LAB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+196,512
Change %
+7.5%
Price
$0.000000
Shares after
2,832,518
Date
04 Apr 2025
Ownership
Direct
LAB transaction

Common Stock

Tax liability

Transaction value
$61,713
Shares
-57,676
Change %
-2%
Price
$1.07
Shares after
2,774,842
Date
04 Apr 2025
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

LAB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-196,512
Change %
-50%
Price
$0.000000
Shares after
196,513
Date
04 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
196,512
Exercise price
Footnotes
F2, F3
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022.
F2 Each RSU represents the contingent right to receive one share of the Issuer's common stock.
F3 On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .